A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Oxamniquine
Vitespen
The therapeutic efficacy of Vitespen can be decreased when used in combination with Nilotinib.
Oxamniquine
GI-5005
The therapeutic efficacy of GI-5005 can be decreased when used in combination with Nilotinib.
Oxamniquine
SRP 299
The therapeutic efficacy of SRP 299 can be decreased when used in combination with Nilotinib.
Oxamniquine
Rindopepimut
The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Nilotinib.
Oxamniquine
INGN 225
The therapeutic efficacy of INGN 225 can be decreased when used in combination with Nilotinib.
Oxamniquine
PEV3A
The therapeutic efficacy of PEV3A can be decreased when used in combination with Nilotinib.
Oxamniquine
G17DT
The therapeutic efficacy of G17DT can be decreased when used in combination with Nilotinib.
Oxamniquine
Osimertinib
The metabolism of Osimertinib can be decreased when combined with Nilotinib.
Oxamniquine
Dexibuprofen
The metabolism of Dexibuprofen can be decreased when combined with Nilotinib.
Oxamniquine
Lorlatinib
The metabolism of Lorlatinib can be decreased when combined with Nilotinib.
Oxamniquine
Beraprost
The metabolism of Beraprost can be decreased when combined with Nilotinib.
Oxamniquine
Licofelone
The metabolism of Licofelone can be decreased when combined with Nilotinib.
Oxamniquine
Artemether
The risk or severity of QTc prolongation can be increased when Nilotinib is combined with Artemether.
Oxamniquine
Terodiline
The risk or severity of QTc prolongation can be increased when Nilotinib is combined with Terodiline.
Oxamniquine
Macimorelin
The risk or severity of QTc prolongation can be increased when Nilotinib is combined with Macimorelin.
Oxamniquine
Glasdegib
The risk or severity of QTc prolongation can be increased when Nilotinib is combined with Glasdegib.
Oxamniquine
Ivabradine
The risk or severity of QTc prolongation can be increased when Nilotinib is combined with Ivabradine.
Oxamniquine
Temafloxacin
The risk or severity of QTc prolongation can be increased when Temafloxacin is combined with Nilotinib.
Oxamniquine
Lithium cation
The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Nilotinib.
Oxamniquine
Halofantrine
The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Nilotinib.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3